4
Feb, 2019
The many challenges of developing drugs appropriately formulated for children are compounded by a series of market factors that make these efforts costly and complex, discouraging drug manufacturers – especially generic drug manufacturers – from prioritizing investments in new paediatric treatment options.
28
Mar, 2018
The meeting aims to provide an update on Contemporary Paediatrics and to present the outputs of the SPaeDD-UK Project.
Co-funded by Innovate UK (the UK’s Innovation Agency, the Smart Paediatric Drug Development (SPaeDD) initiative is a cross company and academic centre initiative to accelerate paediatric formulation development.
2
Feb, 2018
The active participation and the strong interest shown by more of the 100 participants has confirmed that the ID-EPTRI project can count on a collaborative and proficient partnership